National and Kapodistrian University of Athens
Μελέτη του ρόλου της APOJ και του SR-BI υποδοχέα στην παθογένεση της νόσου του Alzheimer σε ένα διαγονιδιακό μοντέλο ποντικών
Abstract
dc:descriptionScavenger receptor class B type I (SR-BI) is a high-density lipoprotein receptor that regulates cholesterol efflux from the peripheral tissues to the liver. SR-BI has been identified on astrocytes and vascular smooth muscle cells in Alzheimer's disease brain and has been shown to mediate adhesion of microglia to fibrillar amyloid-β (Aβ). Here we report that SR-BI mediates perivascular macrophage response and regulates Aβ-related pathology and cerebral amyloid angiopathy in an Alzheimer's mouse model. Reduction or deletion of SR-BI gene in heterozygous or homozygous deficient mice (SRBI +/?, ?/?) resulted in a significant increase in perivascular macrophages in the brain. SR-BI deletion had no effect on apolipoprotein E or apolipoprotein AI levels in the mouse brain. Our analysis revealed increased levels of SR-BI expression in the brains of human amyloid precursor protein (Swedish, Indiana) transgenic mice (J20 line). To evaluate the role of SR-BI in Alzheimer's disease pathogenesis, we inactivated one SR-BI allele in J20 transgenic mice. SR-BI reduction in J20/SR-BI+/? mice enhanced fibrillar amyloid deposition and cerebral amyloid angiopathy and also exacerbated learning and memory deficits compared with J20 littermates. Immunohistochemical analysis revealed localization of SR-BI on perivascular macrophages in tight association with Aβ deposits. Our data suggest that SRBI reduction impairs the response of perivascular macrophages to Aβ and enhances the Aβ-related phenotype and cerebral amyloid angiopathy in J20 mice. These results reveal that SR-BI, a scavenger receptor primarily involved in high-density lipoprotein cholesterol transport, plays an essential role in Alzheimer's disease and cerebral amyloid angiopathy (Thanopoulou et al, 2010). Apolipoprotein J is a highly conserved glycoprotein. Its mRNA and protein have been identified in the human CNS as well as in the CNS of experimental mouse models. ApoJ expression levels are increased after injury and in cases of neurodegenerative diseases. In this study two transgenic mouse models have been created. Both of them express the human ApoJ protein in the brain: the pCALSL/ApoJ/polyA and the PDGF/ApoJ/polyA. The mice from the first model, which is a conditional one, have been mated with the CaMKII-cre mice, so as to achieve expression in the brain. After mRNA analysis of the two models it was decided to continue the study using the PDGF/ApoJ/polyA model. So, these mice were mated with transgenic ones that express a mutated form of the human amyloid precursor protein and a mutated presinilin 1 protein. From the results it was concluded that overexpression of hApoJ leads to increaded amyloid plaque burden in the brain, confirming its importance in the pathogenesis of Alzheimer’s disease.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2010
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Thanopoulou, Kalliopi
- Θανοπούλου, Καλλιόπη
Subjects
dc:subject × 21- Καθαριστής υποδοχέας
- Απολιποπρωτεΐνη J
- Νόσος Alzheimer
- Χοληστερόλη
- Περιαγγειακά μακροφάγα
- Διαγονιδιακά ποντίκια
- Εγκέφαλος
- Μνήμη
- Scavenger receptor
- SRBI
- Apolipoproteins J
- Alzheimer's disease
- Cholesterol
- Perivascular macrophages
- Transgenic mice
- Brain
- Memory
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/24591